BOSTON--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced the Empirica Signal product, a major new release of the company’s flagship signal detection and management software formerly known as WebVDME. Empirica Signal joins the Empirica™ Trace product as the newest component of Phase Forward’s Empirica suite of pharmacovigilance and risk management products, which are developed by the company’s Lincoln Safety Group, one of the most experienced and respected teams in the safety industry.
